Clinical Trial Update: Imatinib in Patients With Desmoid Tumor and Chondrosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for imatinib in patients with advanced desmoid tumor and advanced chondrosarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chondrosarcoma
• Desmoid Tumor

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Italian Sarcoma Group | Conditions: Advanced Desmoid Tumor, Advanced Chondrosarcoma | Phase 2 | Status: COMPLETED